C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2002
10/23/2002	EP0804477B1 Use of a peptide fragment derived from pban(1-33)nh2 for the design of pban antagonists for controlling moths
10/23/2002	CN1376162A Novel techykinin peptides, precursor peptides thereof and genes encoding the same
10/22/2002	US6469137 Myelopeptides and their therapeutic use
10/22/2002	US6469136 Methods and composition for peptide synthesis
10/22/2002	US6468986 Composition comprising polynucleotide and polycationic agent which exhibits net positive electrical charge at physiological ph, and is capable of mediating entry of polynucleotides into cell
10/22/2002	US6468974 Oligopeptides that provide desirable in vitro and in vivo growth hormone releasing activity and have at least one other desirable biological activity such as increased retention time
10/22/2002	US6468972 Method to promote, stimulate and/or delay hair loss by a brady kinin antagonist
10/22/2002	CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/22/2002	CA2022437C Reduced size lhrh analogs
10/17/2002	WO2002081683A2 Protein analysis by means of immobilized arrays of antigens or antibodies
10/17/2002	WO2002081646A2 Epitope sequences
10/17/2002	WO2002081522A1 Anti-osteopontin antibody and use thereof
10/17/2002	WO2002081506A1 Process for producing trunkamide a compounds
10/17/2002	WO2002081505A2 Peptide for the diagnosis and therapy of alzheimer's disease
10/17/2002	WO2002081504A2 Multimerization of hiv-1 vif protein as a therapeutic target
10/17/2002	WO2002081503A1 Novel substances k97-0239 and process for producing the same
10/17/2002	WO2002081499A2 Somatostatin agonists
10/17/2002	WO2002072619A8 INTEGRIN αIIbβ3 ACTIVATING PEPTIDES AND THEIR USE
10/17/2002	WO2002062969A9 Cellular reprogramming in peptide hydrogel and uses thereof
10/17/2002	WO2002010192A9 Somatostatin analogues
10/17/2002	WO2002008247A3 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide
10/17/2002	WO2002002133A3 Peptide composition for treatment of periodontal diseases and prevention of skin aging
10/17/2002	WO2001060391A9 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
10/17/2002	WO2001053330A9 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
10/17/2002	WO2001042423A9 Compositions and methods for detecting stress-inducible proteins
10/17/2002	US20020151679 Peptide for use in the treatment of infections, viral and cancer diseases
10/17/2002	US20020151678 Prophylaxis and therapy of acquired immunodeficiency syndrome
10/17/2002	US20020151676 Streptogramin derivatives, preparation method and compositions containing same
10/17/2002	US20020151571 Activity against arthropods in agriculture and parasites encountered in animal husbandry
10/17/2002	US20020151501 Compounds having growth hormone releasing activity
10/17/2002	US20020151500 Administering a therapeutically effective amount of a type-5 selective somatostatin agonist to patient
10/17/2002	US20020151497 Inhibitors comprise sequences derived from specific regions of the Lyn-kinase
10/17/2002	US20020151475 Compounds and methods for modulating cell adhesion
10/17/2002	US20020151464 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
10/17/2002	US20020150964 Peptides for the activation of the immune system in humans and animals
10/17/2002	CA2827167A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2606839A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2443330A1 Anti-osteopontin antibody and use thereof
10/17/2002	CA2443207A1 Process for producing trunkamide a compounds
10/17/2002	CA2443085A1 Somatostatin agonists
10/17/2002	CA2443067A1 Protein analysis by means of immobilized arrays of antigens or antibodies
10/17/2002	CA2442386A1 Epitope sequences
10/16/2002	EP1249456A1 Novel peptide and screening method by using the same
10/16/2002	EP1248653A2 Gene therapy to promote angiogenesis and/or the treatment of heart failure
10/16/2002	EP1248642A1 Vegf-d/vegf-c/vegf peptidomimetic inhibitor
10/16/2002	EP0868429B1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/16/2002	CN1374321A 肽载体 Peptide carrier
10/16/2002	CN1374320A HAb18G(/CD147) peptide agonist and its prepn and use
10/15/2002	US6465612 Synthetic peptides, conjugation reagents and methods
10/15/2002	US6465430 Treating hematological disorders, particularly thrombo-cytopenia resulting from chemotherapy, radiation therapy or bone marrow transfusions; accelerating blood platelet regeneration
10/15/2002	US6465429 Antimicrobial cationic peptides
10/15/2002	US6465427 Compounds and methods for modulating cell adhesion
10/15/2002	US6465184 Determining gene expression of nucleic acid encoding tumor rejection antigen precursors
10/10/2002	WO2002079408A2 Short bioactive peptides and methods for their use
10/10/2002	WO2002079397A2 Virus derived antimicrobial peptides
10/10/2002	WO2002079234A1 Peptides and their use as inhibitors of hepatitis c virus ns3 protease
10/10/2002	WO2002078683A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002	WO2002078607A2 Mucin peptide with immunoenhancing properties
10/10/2002	WO2002078597A2 Oral absorbed drugs
10/10/2002	WO2002055111A3 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
10/10/2002	WO2002051862A3 Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units
10/10/2002	WO2002051861A3 Process for the synthesis of a peptide having a tryptophan residue
10/10/2002	US20020147306 Peptides that modulate the interaction of B class ephrins and PDZ domains
10/10/2002	US20020147301 Parevins and tachytegrins
10/10/2002	US20020147297 Polystyrene solid support
10/10/2002	US20020147151 IL-16 antagonists
10/10/2002	US20020147150 Sustained-release preparation
10/10/2002	US20020147146 Antidiabetic agents; Alzheimer's disease
10/10/2002	US20020147144 Prevention, therapy autoimmune diseases; anticholesterol agents
10/10/2002	US20020147139 Viricides
10/10/2002	US20020147138 Anticancer agents
10/10/2002	US20020147136 Tetrapeptide
10/10/2002	US20020147133 Bifunctional molecules and therapies based thereon
10/10/2002	US20020147129 Polypeptides; nervous system, brain disorders
10/10/2002	US20020146843 Controlling protein levels in eucaryotic organisms
10/10/2002	US20020146823 Propagating mesenchymal stem cells; obtain cells, incubate in preferentially generated propagation mixture, recover cells
10/10/2002	US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002	US20020146718 Peptide nucleic acids for use in the treatment and prevention of viral diseases, arthritis, infection, skin, cardiovascular, gastrointestinal and kidney disorders
10/10/2002	US20020146695 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample
10/10/2002	CA2443045A1 Mucin peptide with immunoenhancing properties
10/10/2002	CA2442540A1 Peptides and their use as inhibitors of hepatitis c virus ns3 protease
10/10/2002	CA2441970A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002	CA2441562A1 Short bioactive peptides and methods for their use
10/09/2002	EP1247532A1 Composition promoting lacrimal secretion
10/09/2002	EP1247531A2 TNF-derived peptides for use in treating oedema
10/09/2002	EP1246935A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
10/09/2002	EP1246839A1 Depsipeptide and congeners thereof for use as immunosuppressants
10/09/2002	EP1246838A1 Lipopeptides as antibacterial agents
10/09/2002	EP1246837A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides
10/09/2002	EP1246836A2 Peptides for treatment of erectile dysfunction
10/09/2002	EP1246597A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
10/09/2002	EP0880360B1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
10/09/2002	EP0783521B1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/09/2002	EP0769025B1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown
10/09/2002	EP0651761B1 Method for modification of recombinant polypeptides
10/09/2002	CN1373770A Pseudomycin prodrugs
10/09/2002	CN1373139A Carboline carboxylic acid contaiing P6A associated sequence and synthesis and medical application thereof
10/08/2002	US6462173 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
10/08/2002	US6462172 Purification of tissue plasminogen activator (TPA)
10/08/2002	US6462171 Inhibitory peptide for alzheimer*s and prion encephalopathy disease treatment

1 ... 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 ... 423